Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Abraham Garcia-Kutzbach
Correction To: Regional Differences in Baseline Disease Activity and Remission Rates Following Golimumab Treatment for RA: Results From the GO-MORE Trial
Clinical Rheumatology
Medicine
Rheumatology
Related publications
Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Silent Progression in Patients With Rheumatoid Arthritis: Is DAS28 Remission an Insufficient Goal in RA? Results From the German Remission-Plus Cohort
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Reply To: Anti-Carbamylated Protein Antibodies (Anti-CarP) and Higher Baseline Disease Activity in RA, a Replication Study in Three Cohorts
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Baseline Differences in the HF-ACTION Trial by Sex
American Heart Journal
Cardiovascular Medicine
Cardiology
Letter: Effectiveness of Golimumab to Induce Remission in Outpatient Ulcerative Colitis in Italy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Golimumab for the Treatment of Ulcerative Colitis
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Anti-Carbamylated Protein Antibodies (Anti-CarP) and Higher Baseline Disease Activity in RA, a Replication Study in Three Cohorts
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
P146 Golimumab in Rheumatoid and Psoriatic Arthritis. The Relationship Between Minimum Serum Concentration, Anti-Golimumab Antibodies and Activity of Disease
Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
